High number of newly discovered active pharmaceutical ingredients (APIs) are poorly soluble in water which decreases their bioavailability and makes their formulation into a functional pharmaceutical product quite a challenge. One of the possible solutions is amorphization of the API. The amorphous form is thermodynamically less stable and thus generally provides better dissolution kinetics than more stable crystalline states of the APIs. However the amorphous state tends to spontaneously crystallize over time and needs to be stabilized somehow in order to be viably formulated.
There are several methods of achieving stable amorphous formulations. One of them is formulation on porous carriers. The confined space of mesopores prevents the API from crystallizing and in combination with high surface area leads to faster release kinetics. A wide range of possible porous micro- and nano-carriers is being thouroughly studied at the moment in relation to their compatibility with specific APIs, their loading capacity and their effectivity on increasing the dissolution rate.